| RS2145671861 |
PLA2G6
|
Health Risk |
Likely pathogenic |
— |
| RS2145679099 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145679115 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145680059 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145680143 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145680256 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145681074 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145681468 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145682223 |
RYR1
|
Health Risk |
Pathogenic |
Abnormality of the musculature, RYR1-related disorder |
| RS2145682767 |
PLA2G6
|
Health Risk |
Likely pathogenic |
— |
| RS2145682922 |
PLA2G6
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2145682923 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145683127 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, Autosomal recessive Parkinson disease 14 |
| RS2145688683 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS2145689814 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2145695502 |
STK4
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STK4 deficiency, Combined immunodeficiency due to STK4 deficiency |
| RS2145697142 |
EP300
|
Health Risk |
Pathogenic |
EP300-related disorder, EP300-related disorder |
| RS2145697529 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2145697647 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145701153 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS2145701171 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS2145701950 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS2145702012 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS2145702302 |
GTPBP3
|
Health Risk |
Pathogenic |
GTPBP3-related disorder, GTPBP3-related disorder |
| RS2145702358 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145702588 |
NCF4
|
Health Risk |
Likely pathogenic |
Chronic granulomatous disease, Chronic granulomatous disease |
| RS2145703172 |
GTPBP3
|
Health Risk |
Pathogenic |
— |
| RS2145705605 |
MAPK1
|
Health Risk |
Likely pathogenic |
MAPK1-related disorder, MAPK1-related disorder |
| RS2145706114 |
WDR62
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 2, primary |
| RS2145708232 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS2145710946 |
PLA2G6
|
Health Risk |
Likely pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS2145711022 |
PLA2G6
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 2B, Neurodegeneration with brain iron accumulation 2B |
| RS2145711507 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145712063 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145712091 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2145712459 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145712492 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145712498 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145712541 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2145712576 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2145712758 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2145713137 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2145713819 |
EP300
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Colon adenocarcinoma |
| RS2145715515 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2145715677 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145715728 |
EP300
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2145718887 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145718961 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145719551 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2145719697 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2145719797 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2145719805 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145722213 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS2145722278 |
PLA2G6
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2145722767 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2145723826 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145724052 |
SLC25A19
|
Health Risk |
Pathogenic |
Progressive demyelinating neuropathy with bilateral striatal necrosis, Progressive demyelinating neuropathy with bilateral striatal necrosis |
| RS2145724454 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2145725035 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2145725786 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2145726269 |
PRX
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2145727241 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease type 4 |
| RS2145727806 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2145728259 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease type 4F |
| RS2145729186 |
TCF4
|
Health Risk |
Likely pathogenic |
— |
| RS2145729217 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145729499 |
GREB1L
|
Health Risk |
Likely pathogenic |
— |
| RS2145729505 |
PRX
|
Health Risk |
Likely pathogenic |
— |
| RS2145731305 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2145731903 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2145732111 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2145733964 |
PRX
|
Health Risk |
Likely pathogenic |
Developmental cataract, Developmental cataract |
| RS2145734002 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145735332 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 7 |
| RS2145735938 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2145735982 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145736063 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145736248 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145736348 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2145736444 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145736578 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145736622 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145736778 |
KCNQ2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2145736858 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145737748 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145739661 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145740556 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145743494 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145744160 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2145744381 |
DYM
|
Health Risk |
Likely pathogenic |
— |
| RS2145744796 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS2145747771 |
EP300
|
Health Risk |
Likely pathogenic |
EP300-related disorder, EP300-related disorder |
| RS2145747957 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145748011 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145748046 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145748251 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145748275 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145748375 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145748685 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145748708 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |